Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis

Study objectives This meta-analysis analytically reviewed recent studies concerning the potential associations between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and susceptibility to major depressive disorder (MDD), with subgroup analyses for race and age. Methods Relevant case-control studies were systematically searched for in PubMed, Embase, the Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang, and Sinomed databases. A total of 24 studies were finally identified to have reported outcomes including alleles, dominant genes, recessive genes, homozygosity, and heterozygosity. Subgroup meta-analyses were performed based on participant age and ethnicity. Publication bias was represented by funnel plots. All meta-analyses of the randomized controlled trials included for evaluation were performed using RevMan5.3 software. Results The findings revealed no significant association between BDNF Val66Met polymorphism and MDD. However, the Met allele was found to be associated with genetic susceptibility to MDD among white populations on subgroup analysis (OR = 1.25, 95% CI: 1.05–1.48, P = 0.01). In the genetic model, dominant (OR = 1.40, 95% CI: 1.18–1.66, P = 0.0001), recessive (OR = 1.70, 95% CI: 1.05–2.78, P = 0.03), and homozygous (OR = 1.77, 95% CI: 1.08–2.88, P = 0.02) genes were all associated with MDD. Conclusions Despite the outcome limitations, this meta-analysis confirmed that the BDNF Val66Met polymorphism is a susceptibility factor for MDD in white populations.

[1]  M. V. Van Hook.  Brain-derived neurotrophic factor is a regulator of synaptic transmission in the adult visual thalamus. , 2022, Journal of neurophysiology.

[2]  F. Lee,et al.  Acute stress induces an aberrant increase of presynaptic release of glutamate and cellular activation in the hippocampus of BDNFVal/Met mice , 2022, Journal of cellular physiology.

[3]  A. Dasgupta,et al.  Association of the Val66Met polymorphism of the BDNF gene and the deletional mutation of CYP2D6 gene with the prevalence and severity of depressive disorder in an Eastern Indian population , 2022, Indian journal of psychiatry.

[4]  B. Gutiérrez,et al.  Interaction Effect between Physical Activity and the BDNF Val66Met Polymorphism on Depression in Women from the PISMA-ep Study , 2022, International journal of environmental research and public health.

[5]  R. Ramasubbu,et al.  Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessment , 2021, Depression and anxiety.

[6]  Yuqi Cheng,et al.  Brain-derived neurotrophic factor Val66Met polymorphism affects cortical thickness of rostral anterior cingulate in patients with major depressive disorder , 2020, Neuroreport.

[7]  N. Rocha,et al.  Brain-derived neurotrophic factor (BDNF) and inflammatory markers: Perspectives for the management of depression , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  Jingyun Yang,et al.  The association between genetic variants in lactotransferrin and dental caries: a meta- and gene-based analysis , 2020, BMC Medical Genetics.

[9]  M. Trivedi.  Major Depressive Disorder in Primary Care: Strategies for Identification. , 2020, The Journal of clinical psychiatry.

[10]  Ping Liao,et al.  Brain‐derived neurotrophic factor and post‐stroke depression , 2020, Journal of neuroscience research.

[11]  E. Binder,et al.  Epigenetics and depression
 , 2019, Dialogues in clinical neuroscience.

[12]  T. Karagiannis,et al.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression , 2019, Molecular Biology Reports.

[13]  T. Karagiannis,et al.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression , 2019, Molecular Biology Reports.

[14]  Jun Cao,et al.  Plasma brain-derived neurotrophic factor (BDNF) concentration and the BDNF Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder , 2019, Pharmacogenomics and personalized medicine.

[15]  C. Normann,et al.  Recent insights into antidepressant therapy: Distinct pathways and potential common mechanisms in the treatment of depressive syndromes , 2018, Neuroscience & Biobehavioral Reviews.

[16]  A. Rajewska-Rager,et al.  Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression , 2018, Pharmacological reports : PR.

[17]  G. Rosoklija,et al.  Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide , 2017, bioRxiv.

[18]  J. Sarris,et al.  The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression , 2017, Nutritional neuroscience.

[19]  N. Sun,et al.  Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population. , 2016, European review for medical and pharmacological sciences.

[20]  G. Yadid,et al.  Blood BDNF Level Is Gender Specific in Severe Depression , 2015, PloS one.

[21]  J. Bukh,et al.  Are variations in whole blood BDNF level associated with the BDNF Val66Met polymorphism in patients with first episode depression? , 2013, Psychiatry Research.

[22]  S. Salton,et al.  The role of neurotrophins in major depressive disorder , 2013, Translational neuroscience.

[23]  B. Carroll,et al.  Association between the BDNF Val66Met Polymorphism and Chronicity of Depression , 2013, Psychiatry investigation.

[24]  Jingyun Yang,et al.  No association of genetic variants in BDNF with major depression: A meta‐ and gene‐based analysis , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  W. Taylor,et al.  The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[26]  M. Riva,et al.  BDNF Val66Met polymorphism and protein levels in Amniotic Fluid , 2010, BMC Neuroscience.

[27]  N. Akarsu,et al.  The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels , 2010, Brain Research Bulletin.

[28]  Zhijun Zhang,et al.  Lack of association between BDNF Val66Met gene polymorphism and late-onset depression in a Chinese Han population , 2009, Acta Neuropsychiatrica.

[29]  Stephan Züchner,et al.  The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[30]  Stephan Züchner,et al.  Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[31]  Hans-Jürgen Möller,et al.  Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. , 2007, Archives of general psychiatry.

[32]  Jiing-Feng Lirng,et al.  The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression , 2006, Neurobiology of Aging.

[33]  Se-Won Lim,et al.  Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder , 2006, Brain Research.

[34]  C. Siao,et al.  Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior , 2006, Science.

[35]  Margit Burmeister,et al.  BDNF Val66Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects , 2006, Biological Psychiatry.

[36]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[37]  S. Tsai,et al.  Association Study of a Brain-Derived Neurotrophic Factor (Val66Met) Genetic Polymorphism and Panic Disorder , 2004, Neuropsychobiology.

[38]  Kenji Hashimoto,et al.  Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[39]  R. Duman,et al.  Pathophysiology of depression: the concept of synaptic plasticity , 2002, European Psychiatry.

[40]  R. de Graaf,et al.  Determinants of poor 1‐year outcome of DSM‐III‐R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) , 2001, Acta psychiatrica Scandinavica.

[41]  A. Nitta,et al.  Brain‐derived neurotrophic factor prevents neuronal cell death induced by corticosterone , 1999, Journal of neuroscience research.

[42]  R. Bijl,et al.  Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) , 1998, Social Psychiatry and Psychiatric Epidemiology.

[43]  M. Weissman,et al.  Cross-national epidemiology of major depression and bipolar disorder. , 1996, JAMA.

[44]  B. Lu,et al.  BDNF and synaptic plasticity, cognitive function, and dysfunction. , 2014, Handbook of experimental pharmacology.

[45]  M. Hoptman,et al.  Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[46]  K. Hashimoto,et al.  Association between brain‐derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[47]  Margit Burmeister,et al.  A BDNF Coding Variant is Associated with the NEO Personality Inventory Domain Neuroticism, a Risk Factor for Depression , 2003, Neuropsychopharmacology.

[48]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.